Center for Host Defense, Inflammation, and Lung Disease Research, Department of Pediatrics, Pennsylvania State University College of Medicine, Pennsylvania, USA.
Front Biosci (Landmark Ed). 2012 Jan 1;17(2):407-29. doi: 10.2741/3935.
Pulmonary surfactant, a lipoprotein complex, maintains alveolar integrity and plays an important role in lung host defense, and control of inflammation. Altered inflammatory processes and surfactant dysfunction are well described events that occur in patients with acute or chronic lung disease that can develop secondary to a variety of insults. Genetic variants of surfactant proteins, including single nucleotide polymorphisms, haplotypes, and other genetic variations have been associated with acute and chronic lung disease throughout life in several populations and study groups. The hydrophilic surfactant proteins SP-A and SP-D, also known as collectins, in addition to their surfactant-related functions, are important innate immunity molecules as these, among others, exhibit the ability to bind and enhance clearance of a wide range of pathogens and allergens. This review focuses on published association studies of human surfactant proteins A and D genetic polymorphisms with respiratory, and non-respiratory diseases in adults, children, and newborns. The potential role of genetic variations in pulmonary disease or pathogenesis is discussed following an evaluation, and comparison of the available literature.
肺表面活性剂,一种脂蛋白复合物,维持肺泡的完整性,并在肺宿主防御和炎症控制中发挥重要作用。改变的炎症过程和表面活性剂功能障碍是在急性或慢性肺部疾病患者中发生的众所周知的事件,这些疾病可能继发于多种损伤。表面活性剂蛋白的遗传变异,包括单核苷酸多态性、单倍型和其他遗传变异,与几个人群和研究组一生中的急性和慢性肺部疾病有关。亲水性表面活性剂蛋白 SP-A 和 SP-D,也称为集合素,除了它们的表面活性剂相关功能外,还是重要的先天免疫分子,因为它们具有结合和增强清除多种病原体和过敏原的能力。本综述重点介绍了已发表的与人表面活性剂蛋白 A 和 D 遗传多态性与成人、儿童和新生儿呼吸道和非呼吸道疾病相关的关联研究。在评估和比较现有文献后,讨论了遗传变异在肺部疾病或发病机制中的潜在作用。